Microscopic Clues Reveal Potential Drivers of Long COVID

Researchers have uncovered a potential hidden driver behind the prolonged symptoms experienced by some COVID-19 survivors. By analyzing blood samples from long COVID patients, a team of medical researchers has identified unusual microscopic structures that may contribute to symptoms such as brain fog and fatigue.

The study, led by geneticist Alain Thierry of Montpellier University in France, found that long COVID patients had a dramatically higher number of microclots in their blood compared to healthy controls. These microclots were also larger than those typically seen in healthy individuals. Interestingly, the researchers also observed that these microclots were physically embedded with neutrophil extracellular traps (NETs), a phenomenon that had not been reported before.

NETs are sticky webs of DNA and enzymes released by white blood cells to capture and contain pathogens. While they normally do their job and then quickly break down, in long COVID patients, they appear to be persisting and interacting with the microclots in a way that may hinder blood flow and contribute to the prolonged symptoms.

The researchers believe these findings not only present a possible new diagnostic tool for long COVID, but also offer promising therapeutic targets for future treatment. In fact, the differences in microclots and NETs were so pronounced that an AI agent was able to identify long COVID patients with 91% accuracy when the samples were anonymized.

As the reasons behind long COVID remain a medical mystery, this discovery provides a hopeful avenue for further research and potential relief for those living with the condition.